Skip to content
Mainboard BSE,NSE Bidding closed

Trualt Bioenergy IPO Subscription Status

Trualt Bioenergy IPO received bids for 88,85,66,820 shares against 1,23,55,424 offered, an overall subscription of 71.92x at the close of bidding (29 Sep 2025). QIBs lead at 159.22x.

Last updated · day 3 figures

Retail
11.00x
NII
98.56x
QIB
159.22x
Total
71.92x

Where the demand is

Trualt Bioenergy IPO subscription by category Each line starts at 1x (fully subscribed) and ends at the category's subscription multiple, on a logarithmic scale. Values are listed in the table below. 0.1x 1x 10x 100x 1,000x QIB QIB: 159.22x 159.22x NII NII: 98.56x 98.56x bNII bNII: 113.46x 113.46x sNII sNII: 68.76x 68.76x Retail Retail: 11.00x 11.00x Total Total: 71.92x 71.92x
Log scale. Lines run from 1x (fully subscribed): right means more demand than shares, left means shares still unbid.

Trualt Bioenergy IPO subscription by category

Category Shares offered Shares bid Amount bid Subscription
QIB 35,10,508 55,89,31,920 ₹27,723.02 Cr 159.22x
NII 26,53,475 26,15,30,760 ₹12,971.93 Cr 98.56x
bNII above ₹10 lakh 17,68,984 20,07,15,030 ₹9,955.47 Cr 113.46x
sNII ₹2–10 lakh 8,84,491 6,08,15,730 ₹3,016.46 Cr 68.76x
Retail 61,91,441 6,81,04,140 ₹3,377.97 Cr 11.00x
Total 1,23,55,424 88,85,66,820 ₹44,072.91 Cr 71.92x

* Shares Offered and Total Amount are calculated based on the upper price of the issue price range. * The portion of anchor investors (or market makers) is not included in the total number of shares offered.

Trualt Bioenergy IPO subscription day-wise

Category Day 3
QIB 159.22x
NII 98.56x
bNII 113.46x
sNII 68.76x
Retail 11.00x
Total 71.92x
Total added 71.92x

Cumulative figures at the end of each day. Read across a row to see how demand built up. Shading deepens as subscription rises above 1x; "Total added" is how much overall subscription grew that day.

Trualt Bioenergy IPO reservation

Category Shares Share of issue
Qualified Institutional Buyers 35,10,508 28.41%
Non-Institutional Investors 26,53,475 21.48%
bNII · above ₹10 lakh 17,68,984 67% of NII
sNII · ₹2–10 lakh 8,84,491 33% of NII
Retail Individual Investors 61,91,441 50.11%
Public issue 1,23,55,424 100%

Allotment Chances Note

These are estimates from the latest application and subscription figures. Actual chances are usually somewhat better, because:

  • Not every bid is at the cut-off price. Bids below the final issue price are rejected before the lottery, so fewer applications compete.
  • Multiple-lot applications count once. In an oversubscribed retail or sNII portion, each application gets at most one minimum lot in the draw, however many lots it bid for.
  • Invalid applications drop out. Unapproved UPI mandates, PAN mismatches and duplicate applications are removed before allotment.

Applying for more lots in the retail category does not improve your odds; applying from separate family accounts does.

Trualt Bioenergy IPO subscription: FAQs

What is the overall subscription of Trualt Bioenergy IPO?
Trualt Bioenergy IPO is subscribed 71.92x overall as of day 3 (29 September 2025), with bids for 88,85,66,820 shares against 1,23,55,424 offered.
What is the retail subscription of Trualt Bioenergy IPO?
The retail portion is subscribed 11.00x as of day 3 (29 September 2025).
What is the QIB and NII subscription of Trualt Bioenergy IPO?
QIBs have subscribed 159.22x of their portion, and NIIs 98.56x (bNII 113.46x, sNII 68.76x) as of day 3 (29 September 2025).
How can I check Trualt Bioenergy IPO subscription status live?
This page shows category-wise and day-wise figures and is updated during bidding hours. The same data is published on the BSE and NSE websites under the issue name.
How do I apply for Trualt Bioenergy IPO?
Apply online through your broker or bank using UPI or ASBA. Choose the IPO, enter the number of lots and bid price (retail investors can bid at the cut-off price), and approve the UPI mandate before the issue closes on 29 September 2025.

Subscription figures are compiled from BSE and NSE bid data and can be revised by the exchanges after the issue closes. For information only; not investment advice.